SMC2
Basic information
Region (hg38): 9:104094259-104141419
Previous symbols: [ "SMC2L1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (55 variants)
- not provided (8 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 53 | 60 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 1 | |||||
Total | 0 | 0 | 55 | 3 | 5 |
Variants in SMC2
This is a list of pathogenic ClinVar variants found in the SMC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-104095434-G-A | not specified | Uncertain significance (Sep 30, 2021) | ||
9-104095467-A-G | not specified | Uncertain significance (Jun 10, 2022) | ||
9-104096272-A-C | not specified | Uncertain significance (Feb 07, 2023) | ||
9-104098498-A-C | Likely benign (Aug 03, 2017) | |||
9-104100107-A-G | not specified | Uncertain significance (Jan 22, 2024) | ||
9-104100147-A-G | not specified | Uncertain significance (Aug 12, 2021) | ||
9-104100202-C-T | not specified | Uncertain significance (Sep 28, 2022) | ||
9-104101961-A-G | not specified | Uncertain significance (Jul 14, 2023) | ||
9-104101967-C-G | not specified | Uncertain significance (Feb 07, 2023) | ||
9-104102017-C-T | not specified | Uncertain significance (Apr 06, 2023) | ||
9-104102029-G-T | not specified | Uncertain significance (Mar 06, 2023) | ||
9-104102043-G-T | not specified | Uncertain significance (Feb 14, 2023) | ||
9-104102050-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
9-104102066-G-A | not specified | Uncertain significance (Nov 27, 2023) | ||
9-104102126-C-T | not specified | Uncertain significance (Aug 04, 2023) | ||
9-104102152-C-T | Benign (Dec 31, 2019) | |||
9-104102427-A-C | not specified | Uncertain significance (Jun 28, 2022) | ||
9-104102442-C-T | Uncertain significance (Oct 11, 2023) | |||
9-104102499-G-A | not specified | Uncertain significance (Jun 12, 2023) | ||
9-104102499-G-T | not specified | Uncertain significance (Jun 30, 2023) | ||
9-104102526-G-A | Benign (Jul 23, 2018) | |||
9-104111667-T-C | Benign (Dec 31, 2019) | |||
9-104111669-C-T | not specified | Uncertain significance (Apr 19, 2023) | ||
9-104111713-G-T | not specified | Uncertain significance (Apr 25, 2022) | ||
9-104111759-G-T | not specified | Uncertain significance (Aug 02, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SMC2 | protein_coding | protein_coding | ENST00000286398 | 24 | 47158 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000102 | 125714 | 0 | 29 | 125743 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.06 | 517 | 589 | 0.877 | 0.0000284 | 7918 |
Missense in Polyphen | 85 | 155.81 | 0.54553 | 2139 | ||
Synonymous | -0.486 | 209 | 200 | 1.04 | 0.00000935 | 2150 |
Loss of Function | 6.32 | 8 | 61.4 | 0.130 | 0.00000323 | 813 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000185 | 0.000182 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000346 | 0.000326 |
Finnish | 0.0000466 | 0.0000462 |
European (Non-Finnish) | 0.000107 | 0.000105 |
Middle Eastern | 0.000346 | 0.000326 |
South Asian | 0.000214 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Central component of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. {ECO:0000269|PubMed:11136719}.;
- Pathway
- Retinoblastoma (RB) in Cancer;Condensation of Prophase Chromosomes;Mitotic Prophase;Condensation of Prometaphase Chromosomes;Mitotic Prometaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic;Aurora B signaling
(Consensus)
Recessive Scores
- pRec
- 0.387
Intolerance Scores
- loftool
- 0.175
- rvis_EVS
- -0.64
- rvis_percentile_EVS
- 16.74
Haploinsufficiency Scores
- pHI
- 0.889
- hipred
- Y
- hipred_score
- 0.800
- ghis
- 0.694
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.543
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Smc2
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype;
Gene ontology
- Biological process
- mitotic chromosome condensation;meiotic chromosome condensation;meiotic chromosome segregation;cell division;kinetochore organization
- Cellular component
- nuclear chromosome;condensed chromosome;condensin complex;nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol;extracellular exosome
- Molecular function
- single-stranded DNA binding;protein binding;ATP binding;protein heterodimerization activity